lemon wishes

we are grateful that the ALSF and its supporters have shared with us some of the 'lemon wishes'.  For the ALSF Spring newsletter, click here.  

Banbury Conference on Rhabdomyosarcoma

This past week the Cold Spring Harbor Laboratory held a special Banbury Conference to critically examine scientific and translational progress in rhabdomyosarcoma.  Through the kind sponsorship of members of the community, an international group of clinicians, cancer scientists and muscle biologists met to discuss driving clinical & biological problems in pediatric, adolescent and young adult rhabdomyosarcoma.  From this meeting will come a "white paper" describing prioritizes areas for further development - and collaborative opportunities.  We are grateful to the CSHL Banbury staff, as well as the CSHL leadership, for making this very unique meeting possible.  

Congratulations, Noah!

Congratulations to Noah, visiting engineering student from the Pal laboratory, whose manuscript, "An integrated approach to anti-cancer drug sensitivity prediction" is now published in IEEE/ACM Transactions on Computational Biology and Bioinformatics.  

Imran's paper published in PNAS

Many congratulations to Imran for his publication, PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma, today in the Proceedings of the National Academy of Sciences of the USA.  This study was a collaboration of the Tyner, Druker and Keller laboratories - highlighting some key growth factor receptor targets in this disease.  This study was funded in part by the Howard Hughes Medical Institute, the National Cancer Institute, and the Joanna McAfee Childhood Cancer Foundation.       

COG Spring meeting

The Fall COG meeting was held in St Louis this past week.  The soft tissue sarcoma session, and corresponding Ewing's-Rhabdomyosarcoma Biology session, were very productive.  

Northwest Sarcoma Foundation initiative

We are grateful for the $25,000 directed gift from the Northwest Sarcoma Foundation that facilitates Seattle-Portland collaboration in the genetic and functional characterization of adult bone and soft tissue sarcomas.  This is the second year of this program, which supports collaboration between our laboratory and Dr. Robin Jones at the Seattle Cancer Care Alliance.  

SARC Sarcoma Developmental Research Program

We are grateful to the SARC SPORE pilot grants program which has awarded a 2nd year of funding to our collaboration with Dave Langenau's lab at MGH evaluating myodifferentiation therapies for rhabdomyosarcoma.